Home Page

To improve service quality,
we will perform maintenance at the following time.


  • April 23, 2022 (Saturday), 08:00 to 21:00 GMT +9 (thirteen hours)

During this time, our website will be unavailable.
Please accept our sincere apologies for any inconveniences which this may cause.

Bioneer, COVID, COVID19, COVID-19, Omicron
SARS-CoV-2 mutations, SARS-CoV-2, COVID-19
Bioneer AccuLoader
Bioneer AccuLoader


On February 25, 2021, BIONEER Corporation announced the launching of a new concept auxiliary device, “AccuLoader™,” designed to assist with the dispensation of samples and reagents to the correct wells and reduce the time spent on the sample preparation. 

AccuLoader™ is the world’s first patented precision auxiliary device developed by BIONEER Corporation. It can be applied to various molecular diagnostic tests, including COVID-19 tests. The device has a variety of functions ranging from scanning the information on a sample tube to automatically adjusting the position of the well for correct sample dispensation. It is also equipped with parts that aid in minimizing the chances of cross-contamination. Moreover, its dedicated mobile app, the “AccuLoader,” allows for managing and merging of all sample information collected from the same run.

For more information, please refer to our Press Release.

Copyright© 2022 BIONEER CORPORATION. All rights reserved.